IRME Stock Overview
A medical device company, engages in the development of non-invasive devices for various medical indications. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
IR-Med Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.53 |
| 52 Week High | US$1.65 |
| 52 Week Low | US$0.34 |
| Beta | 1.54 |
| 1 Month Change | 9.38% |
| 3 Month Change | 5.00% |
| 1 Year Change | -65.00% |
| 3 Year Change | -76.14% |
| 5 Year Change | -99.13% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| IRME | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.08% | -0.8% |
| 1Y | -65.0% | 13.6% | 22.7% |
Return vs Industry: IRME underperformed the US Medical Equipment industry which returned 13.7% over the past year.
Return vs Market: IRME underperformed the US Market which returned 22.6% over the past year.
Price Volatility
| IRME volatility | |
|---|---|
| IRME Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.7% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: IRME's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine IRME's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 8 | Ran Ziskind | www.ir-medical.com |
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company’s development products pipeline consists of PressureSafe, a handheld optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of the foot and diabetes; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
IR-Med Inc. Fundamentals Summary
| IRME fundamental statistics | |
|---|---|
| Market cap | US$37.28m |
| Earnings (TTM) | -US$2.89m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-12.9x
P/E RatioIs IRME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IRME income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.89m |
| Earnings | -US$2.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.041 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 7,750.0% |
How did IRME perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 02:44 |
| End of Day Share Price | 2025/01/29 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IR-Med Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Thomas Kerr | Zacks Small-Cap Research |